Combined use of erythropoiesis-stimulating agents and transfusion guidelines in NICU infants
Seminars in Fetal and Neonatal Medicine · 2026
DOI: 10.1016/j.siny.2026.101718 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Fetal and Neonatal Medicine, 2026. Verfasst von Robin K Ohls. Beteiligte Einrichtung: Division of Neonatology, University of Utah Health, 295 Chipeta Way, Salt Lake City, UT, 84132, USA. Electronic address: robin.ohls@hsc.utah.edu. Hauptthemen laut MEDLINE: Erythrocyte Transfusion, Hematinics, Anemia, Neonatal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: NIH.
Themen: Neonatologie
Abstract (Originalsprache)
Red blood cell transfusions from adult donors can be lifesaving for neonates with severe anemia or acute massive hemorrhage but can be associated with specific and significant risks. Infectious transmission, acute lung injury, and circulatory overload are well known risks and are part of blood transfusion informed consent. Less well-described, but more common, are the risks that occur when transfusing the smallest and most immature neonates, those less than 1000 g. Repeated adult red cell transfusions may worsen inflammatory conditions, such as pulmonary inflammation, and they can increase the incidence and severity of retinopathy of prematurity and neurodevelopmental delay. In this review, we will provide an overview of neonatal transfusion stewardship including instituting both non-pharmacological transfusion-avoidance techniques and pharmacologic strategies to reduce transfusion rates. Erythropoiesis-stimulating agents like erythropoietin and darbepoetin further reduce and can eliminate the need for a transfusion. Instituting non-pharmacologic and pharmacologic strategies will increase the number of NICU infants who remain transfusion free, even those born weighing less than 1000 g.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neonatology, University of Utah Health, 295 Chipeta Way, Salt Lake City, UT, 84132, USA. Electronic address: robin.ohls@hsc.utah.edu.
Förderung
- NIH
Zitieren
APA
Ohls, R. K. (2026). Combined use of erythropoiesis-stimulating agents and transfusion guidelines in NICU infants. Seminars in Fetal and Neonatal Medicine. https://doi.org/10.1016/j.siny.2026.101718
Vancouver
Ohls RK. Combined use of erythropoiesis-stimulating agents and transfusion guidelines in NICU infants. Seminars in Fetal and Neonatal Medicine. 2026. doi:10.1016/j.siny.2026.101718
BibTeX
@article{Ohls2026,
author = {Ohls, Robin K},
title = {Combined use of erythropoiesis-stimulating agents and transfusion guidelines in NICU infants},
journal = {Seminars in Fetal and Neonatal Medicine},
year = {2026},
doi = {10.1016/j.siny.2026.101718}
}
EUVIMED